Published in Biomarkers on January 19, 2015
MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet (2004) 37.83
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59
The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell (2007) 7.99
Epigenetics in cancer. Carcinogenesis (2009) 7.49
Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A (2009) 6.91
Metabolism and disposition kinetics of nicotine. Pharmacol Rev (2005) 6.66
Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods (2010) 6.25
MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol (2009) 5.92
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res (2007) 5.62
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer (2010) 5.57
Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal (2009) 4.73
Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res (2012) 4.06
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis (2009) 3.45
Haemolysis during sample preparation alters microRNA content of plasma. PLoS One (2011) 2.92
Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J (2008) 2.58
Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics (2009) 2.39
Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods (2012) 2.25
Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One (2011) 2.24
miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol (2011) 1.78
MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett (2012) 1.73
Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol (2011) 1.73
DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer (2009) 1.66
let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci (2011) 1.65
MicroRNA turnover: when, how, and why. Trends Biochem Sci (2012) 1.55
Molecular epidemiology of lung cancer. Ann Oncol (1999) 1.48
Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer (2011) 1.38
Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer (2011) 1.38
Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37
MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Mol Cancer (2014) 1.14
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail (2013) 1.09
Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep (2009) 1.04
Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res (2012) 0.98
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult Scler (2013) 0.96
Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicol Appl Pharmacol (2013) 0.93
Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer (2013) 0.92
Circulating microRNAs as biomarkers for inflammatory diseases. Microrna (2013) 0.90
A single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes. BMC Public Health (2013) 0.87
Plasma microRNA expression and micronuclei frequency in workers exposed to polycyclic aromatic hydrocarbons. Environ Health Perspect (2014) 0.86
Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis. Mediators Inflamm (2014) 0.85
MicroRNAs as potential biomarkers of smoking-related diseases. Biomark Med (2012) 0.84
miRNAs in breast cancer: ready for real time? Pharmacogenomics (2012) 0.83
A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokers. Biomarkers (2014) 0.80
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care (2006) 3.37
Mitoferrin is essential for erythroid iron assimilation. Nature (2006) 2.99
Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol (2006) 2.94
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol (2005) 2.80
A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain. BMC Dev Biol (2005) 2.08
Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Am J Hypertens (2007) 2.06
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J (2005) 1.78
Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation (2008) 1.68
The utility of gestures in patients with chest discomfort. Am J Med (2007) 1.54
Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J Biol Chem (2004) 1.31
Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med (2002) 1.20
The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J Nutr (2006) 1.00
Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J Nutr Biochem (2009) 0.98
Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy. Clin Infect Dis (2008) 0.97
Site-directed mutagenesis studies of the hypoxia-inducible factor-1alpha DNA-binding domain. Biochim Biophys Acta (2002) 0.94
Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. J Am Coll Cardiol (2010) 0.93
Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide. Br J Clin Pharmacol (2011) 0.87
Remodeling of small intramyocardial coronary arteries distal to a severe epicardial coronary artery stenosis. Arterioscler Thromb Vasc Biol (2002) 0.87
A Paddock to reef monitoring and modelling framework for the Great Barrier Reef: Paddock and catchment component. Mar Pollut Bull (2012) 0.86
Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes. Regul Toxicol Pharmacol (2013) 0.86
Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population. Nutr Metab (Lond) (2006) 0.86
Metabolic characterization of cell systems used in in vitro toxicology testing: lung cell system BEAS-2B as a working example. Toxicol In Vitro (2013) 0.84
Modulation of interprotomer relationships is important for activation of dimeric calcium-sensing receptor. J Biol Chem (2004) 0.83
Pulse pressure and coronary atherosclerosis progression in postmenopausal women. Hypertension (2004) 0.83
The history of the coronary care unit. Can J Cardiol (2005) 0.82
Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach. Biomarkers (2013) 0.82
Duration of abnormal SPECT myocardial perfusion imaging following resolution of acute ischemia: an angioplasty model. J Am Coll Cardiol (2003) 0.82
Women do benefit from lipid lowering: latest clinical trial data. Cardiol Rev (2002) 0.81
Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. Am Heart J (2007) 0.80
A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokers. Biomarkers (2014) 0.80
Women's angiographic vitamin and estrogen trial: design and methods. Control Clin Trials (2002) 0.79
CYP1A1/1B1 and CYP2A6/2A13 activity is conserved in cultures of differentiated primary human tracheobronchial epithelial cells. Toxicol In Vitro (2011) 0.79
Hypo- and hyperresponse to egg cholesterol predicts plasma lutein and beta-carotene concentrations in men and women. J Nutr (2006) 0.78
Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. Am J Cardiol (2003) 0.77
Mechanical or metabolic treatment for coronary disease: synergistic, not antagonistic, approaches. Cardiol Rev (2002) 0.77
Application of CE-MS to a metabonomics study of human urine from cigarette smokers and non-smokers. Bioanalysis (2014) 0.76
L-carnitine increases liver alpha-tocopherol and lowers liver and plasma triglycerides in aging ovariectomized rats. J Nutr Biochem (2007) 0.76
Lessons from the PROVE-IT trial. Higher dose of potent statin better for high-risk patients. Cleve Clin J Med (2004) 0.76
Reference change values to assess changes in concentrations of biomarkers of exposure in individuals participating in a cigarette-switching study. Clin Chem Lab Med (2014) 0.75
Management of the infant born to a mother with HIV infection. Pediatr Clin North Am (2004) 0.75
Global critical care update. Nurs Crit Care (2016) 0.75
Nicotine, cotinine, and b-nicotyrine inhibit NNK-induced DNA-strand break in the hepatic cell line HepaRG. Toxicol In Vitro (2014) 0.75
Regulating our emergency care paramedics. N Z Med J (2015) 0.75